Silybin inhibits human NSCLC cell growth by regulating the expression and function of key cell cycle regulators, reducing the protein levels of G1‐related CDK2, 4, 6 and their corresponding cyclins‐D1 and D3, and inducing arrest of the cell cycle at G1.199. Here, CDK2 is linked to non-small cell lung carcinoma.